1. Home
  2. AREN vs ATNM Comparison

AREN vs ATNM Comparison

Compare AREN & ATNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AREN
  • ATNM
  • Stock Information
  • Founded
  • AREN 2016
  • ATNM 2000
  • Country
  • AREN United States
  • ATNM United States
  • Employees
  • AREN N/A
  • ATNM N/A
  • Industry
  • AREN Medical/Dental Instruments
  • ATNM Biotechnology: Pharmaceutical Preparations
  • Sector
  • AREN Health Care
  • ATNM Health Care
  • Exchange
  • AREN Nasdaq
  • ATNM Nasdaq
  • Market Cap
  • AREN 64.1M
  • ATNM 56.5M
  • IPO Year
  • AREN N/A
  • ATNM N/A
  • Fundamental
  • Price
  • AREN $1.34
  • ATNM $1.17
  • Analyst Decision
  • AREN
  • ATNM Strong Buy
  • Analyst Count
  • AREN 0
  • ATNM 4
  • Target Price
  • AREN N/A
  • ATNM $8.75
  • AVG Volume (30 Days)
  • AREN 27.4K
  • ATNM 166.1K
  • Earning Date
  • AREN 03-31-2025
  • ATNM 03-28-2025
  • Dividend Yield
  • AREN N/A
  • ATNM N/A
  • EPS Growth
  • AREN N/A
  • ATNM N/A
  • EPS
  • AREN N/A
  • ATNM N/A
  • Revenue
  • AREN $234,396,000.00
  • ATNM $81,000.00
  • Revenue This Year
  • AREN $12.73
  • ATNM $138.42
  • Revenue Next Year
  • AREN $71.95
  • ATNM $16,957.05
  • P/E Ratio
  • AREN N/A
  • ATNM N/A
  • Revenue Growth
  • AREN 45.45
  • ATNM N/A
  • 52 Week Low
  • AREN $0.56
  • ATNM $1.07
  • 52 Week High
  • AREN $2.18
  • ATNM $10.24
  • Technical
  • Relative Strength Index (RSI)
  • AREN 47.02
  • ATNM 46.97
  • Support Level
  • AREN $1.20
  • ATNM $1.15
  • Resistance Level
  • AREN $1.50
  • ATNM $1.29
  • Average True Range (ATR)
  • AREN 0.18
  • ATNM 0.07
  • MACD
  • AREN -0.02
  • ATNM 0.01
  • Stochastic Oscillator
  • AREN 23.73
  • ATNM 46.51

About AREN The Arena Group Holdings Inc.

The Arena Group Holdings Inc is a tech-powered media company that fuses technology, iconic brands, and marketing to deliver vibrant content and experiences that reach million users each month. The company creates robust digital destinations that delight consumers with powerful journalism, news about the things such as favorite sports teams, advice on investing, the inside scoop on personal finance, and the latest on lifestyle essentials. The Company operates in one reportable segment which focuses on a publishing platform. The company generates revenue from Digital and Print, where the majority is generated from Digital. The company owns and operates TheStreet, The Spun, Parade, and Men's Journal and powers more than 320 independent Publisher Partners.

About ATNM Actinium Pharmaceuticals Inc. (Delaware)

Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of radiotherapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest to kill those cells safely and effectively. Its product candidates are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used for hematopoietic stem cells transplantation in various indications and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia.

Share on Social Networks: